The role of mitochondria in health and disease.

Abstract:

:Mitochondria play a key role in energy metabolism in many tissues, including skeletal muscle and liver. Inherent disorders of mitochondria such as DNA deletions cause major disruption of metabolism and can result in severe impairment or death. However, the occurrence of such disorders is extremely rare and cannot account for the majority of metabolic disease. Recently, mitochondrial dysfunction of a more subtle nature in skeletal muscle has been implicated in the pathology of chronic metabolic disease characterized by insulin resistance such as obesity, type 2 diabetes mellitus, and aging. This hypothesis has been substantiated by work from Shulman and colleagues, showing that reduced mitochondrial oxidative capacity underlies the accumulation of intramuscular fat causing insulin resistance with aging. However, recent work by Nair and coworkers has demonstrated that mitochondrial activity may actually be higher in persons exposed to high-calorie diet leading to obesity, suggesting that the accumulation of intramuscular fat and associated fatty acid metabolites may be directly responsible for the development of insulin resistance, independent of mitochondrial function. These inconsistent findings have promoted ongoing investigation into mitochondrial function to determine whether impaired function is a cause or consequence of metabolic disorders.

journal_name

Curr Opin Pharmacol

authors

Johannsen DL,Ravussin E

doi

10.1016/j.coph.2009.09.002

subject

Has Abstract

pub_date

2009-12-01 00:00:00

pages

780-6

issue

6

eissn

1471-4892

issn

1471-4973

pii

S1471-4892(09)00135-0

journal_volume

9

pub_type

杂志文章,评审
  • Cell death and cancer therapy.

    abstract::Successful cancer therapy requires the selective killing of cancer cells. Many molecular components of the pathways that lead to cell death have recently been identified and a number of these, including p53, Apaf-1, and members of the inhibitor of apoptosis protein and Bcl-2 gene families, have been found to be altere...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(01)00059-5

    authors: Bunz F

    更新日期:2001-08-01 00:00:00

  • Chronotherapy of cardiac and vascular disease: timing medications to circadian rhythms to optimize treatment effects and outcomes.

    abstract::Circadian rhythms impact cardiac and vascular pathophysiology, resulting in 24-hour patterning of symptoms and life-threatening/ending events (chronopathology), plus kinetics and dynamics of medications (chronopharmacology), resulting in administration-time differences in efficacy and safety. Scheduling medications ac...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2020.10.014

    authors: Smolensky MH,Hermida RC,Geng YJ

    更新日期:2020-12-03 00:00:00

  • Inhibition of poly(ADP-ribose) polymerase in cancer.

    abstract::Inhibition of the DNA repair enzyme poly(ADP-ribose) polymerase-1 (PARP-1) has been extensively investigated in the pre-clinical setting as a strategy for chemo- or radio-potentiation. Recent evidence has suggested that PARP inhibitors might be active as single agents in certain rare inherited cancers that carry DNA r...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2006.02.004

    authors: Plummer ER

    更新日期:2006-08-01 00:00:00

  • Purinergic receptors and the inflammatory response mediated by lipids.

    abstract::The inflammatory response is regulated by the production of different extracellular mediators, including lipids and extracellular nucleotides. In the extracellular environment, intermediate lipids activate specific G-protein-coupled receptors (GPCRs) in target cells and promote cell recruitment and activation. Extrace...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2019.02.004

    authors: Alarcón-Vila C,Pizzuto M,Pelegrín P

    更新日期:2019-08-01 00:00:00

  • Strontium as therapy for osteoporosis.

    abstract::Osteoporosis is characterized by low bone mass and increased susceptibility to fracture. Recent in vitro studies showed that strontium ranelate, a novel agent containing two strontium atoms, acts as an effective anti-osteoporotic drug by inhibiting bone resorption by osteoclasts and promoting osteoblast replication an...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2005.05.005

    authors: Marie PJ

    更新日期:2005-12-01 00:00:00

  • Therapeutic potential of group III metabotropic glutamate receptor ligands in pain.

    abstract::Metabotropic glutamate receptors (mGluRs) modulate neurotransmission all along the pain neuraxis. While the involvement of group I and group II mGluRs in pain is well documented, information has only just started to emerge concerning the role and contribution of group III mGluRs subtypes to pain modulation. Recent dat...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2014.11.007

    authors: Acher F,Goudet C

    更新日期:2015-02-01 00:00:00

  • Oestrogen's regulation of fat metabolism during exercise and gender specific effects.

    abstract::Early animal, menstrual phase and gender comparative studies inconsistently support an oestrogen-induced increase in fat oxidation during exercise. Recent advances from studies of cellular signalling and gene expression provide evidence for inter-tissue and intramuscular mechanisms that demonstrate oestrogen's promoti...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2012.02.008

    authors: Oosthuyse T,Bosch AN

    更新日期:2012-06-01 00:00:00

  • Contribution of heteromerization to G protein-coupled receptor function.

    abstract::G protein-coupled receptors (GPCRs) are a remarkably multifaceted family of transmembrane proteins that exert a variety of physiological effects. Although family A GPCRs are able to operate as monomers, there is increasing evidence that heteromerization represents a fundamental aspect of receptor function, trafficking...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2016.10.006

    authors: Gaitonde SA,González-Maeso J

    更新日期:2017-02-01 00:00:00

  • Immunomodulation in stem-cell transplantation.

    abstract::Acute graft-versus-host disease is a complication that affects 30-60% of patients undergoing allogeneic stem-cell transplantation. The standard for prophylaxis for graft-versus-host disease has historically been the combination of cyclosporine and methotrexate. Recently, tacrolimus has been used more frequently and cu...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(02)00174-1

    authors: Abo-Zena RA,Horwitz ME

    更新日期:2002-08-01 00:00:00

  • Drugs targeting functional bowel disorders: insights from animal studies.

    abstract::Increased understanding of gastrointestinal pathophysiology in functional bowel disorders is leading to improved focus on relevant enteric, vagal and spinal afferent nervous systems, and targets operating on these systems. These targets include receptors for tachykinins, motilin, ghrelin, corticotropin-releasing facto...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(02)00228-x

    authors: Sanger GJ,Hicks GA

    更新日期:2002-12-01 00:00:00

  • Emerging therapies in bone metastasis.

    abstract::Skeletal lesions contribute substantially to morbidity and mortality in patients with cancer. Emerging treatments for metastatic bone disease have arisen from our understanding of the biology of bone metastases. Tumour cells alter the functions of bone-resorbing (osteoclasts) and bone-forming (osteoblasts) cells, prom...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2015.04.004

    authors: Clément-Demange L,Clézardin P

    更新日期:2015-06-01 00:00:00

  • Peptides as cancer vaccines.

    abstract::Cancer vaccines based on synthetic peptides are a safe, well-tolerated immunotherapy able to specifically stimulate tumor-reactive T cells. However, their clinical efficacy does not approach that achieved with other immunotherapies such as immune checkpoint blockade. Nevertheless, major advances have been made in sele...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2019.01.007

    authors: Calvo Tardón M,Allard M,Dutoit V,Dietrich PY,Walker PR

    更新日期:2019-08-01 00:00:00

  • Targeting CYP17: established and novel approaches in prostate cancer.

    abstract::There is a growing body of evidence that although medical or surgical castration blocks the generation of gonadal testosterone in prostate cancer, androgens originating from other sources may continue to drive androgen receptor (AR) signaling. Recent studies have demonstrated high intratumoral levels of androgens and ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2008.06.004

    authors: Yap TA,Carden CP,Attard G,de Bono JS

    更新日期:2008-08-01 00:00:00

  • Disentangling the heterogeneity of adulthood-onset non-autoimmune diabetes: a little closer but lot more to do.

    abstract::Diabetes diagnosed in adults is a highly heterogeneous disorder. It mostly consists of what is referred to as type 2 diabetes but also comprises other entities (i.e. different diseases), including latent autoimmune diabetes, late onset forms of monogenic diabetes and familial diabetes of the adulthood, which has recen...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2020.10.020

    authors: Trischitta V,Prudente S,Doria A

    更新日期:2020-12-01 00:00:00

  • Glucocorticoids and 11β-hydroxysteroid dehydrogenases: mechanisms for hypertension.

    abstract::Glucocorticoid excess induces hypertension, in which abnormal renal sodium homeostasis is implicated. It is common in industrialised nations where hypertension remains the major risk-factor for cardiovascular disease. Aldosterone is the dominant chronic regulator in sodium homeostasis, but glucocorticoids influence re...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2015.01.005

    authors: Hunter RW,Bailey MA

    更新日期:2015-04-01 00:00:00

  • Clostridium difficile: new therapeutic options.

    abstract::Clostridium difficile disease is the major, known cause of nosocomial diarrhea and is an emerging cause of community-associated diarrhea. Recent outbreaks due to a strain of apparent increased virulence, BI/NAP1, and recognition of increasing metronidazole treatment failures as well as the morbidity associated with re...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2007.05.007

    authors: Balagopal A,Sears CL

    更新日期:2007-10-01 00:00:00

  • Biased ligands: pathway validation for novel GPCR therapeutics.

    abstract::G protein-coupled receptors (GPCRs), in recent years, have been shown to signal via multiple distinct pathways. Furthermore, biased ligands for some receptors can differentially stimulate or inhibit these pathways versus unbiased endogenous ligands or drugs. Biased ligands can be used to gain a deeper understanding of...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2014.04.002

    authors: Rominger DH,Cowan CL,Gowen-MacDonald W,Violin JD

    更新日期:2014-06-01 00:00:00

  • Cancer gene therapy with T cell receptors and chimeric antigen receptors.

    abstract::Viral and non-viral gene transfer technologies have been used to efficiently generate therapeutic T cells with desired cancer-specificity. Chimeric antigen receptors (CARs) redirect T cell specificity toward antibody-recognized antigens expressed on the surface of cancer cells, while T cell receptors (TCRs) extend the...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2015.08.006

    authors: Stauss HJ,Morris EC,Abken H

    更新日期:2015-10-01 00:00:00

  • Role of the P2X4 receptor in neuropathic pain.

    abstract::Neuropathic pain is the most important type of chronic pain because it is refractory to available medications. Neuropathic pain occurs after peripheral nerve injury (PNI) or nerve damage by various reasons. In recent decades, a growing body of evidence shows that spinal microglia and P2X4 receptor (P2X4R), a subtype o...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2019.02.001

    authors: Inoue K

    更新日期:2019-08-01 00:00:00

  • 5-HT(6) receptor and cognition.

    abstract::Since its discovery in 1993 and subsequent development of selective antagonists, a growing number of studies support the use of serotonin 5-HT(6) receptor antagonism as a promising mechanism for treating cognitive dysfunction. Lately, several studies with structurally different compounds have shown that not only antag...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2011.01.004

    authors: Codony X,Vela JM,Ramírez MJ

    更新日期:2011-02-01 00:00:00

  • Promising pharmacologic innovations in treating pulmonary fibrosis.

    abstract::Idiopathic pulmonary fibrosis is the most common form of the interstitial lung diseases and is characterized by chronic progressive pulmonary parenchymal fibrosis. Although the diagnosis and pathophysiology of this disease have been better characterized over the past few years, there remains no effective therapy for t...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2006.03.003

    authors: Bhatt N,Baran CP,Allen J,Magro C,Marsh CB

    更新日期:2006-06-01 00:00:00

  • Antibody therapy for rheumatoid arthritis.

    abstract::High-quality monoclonal antibodies (mAbs) with specificity for relevant disease molecules can now be produced in abundance. Anti-tumour necrosis factor-alpha therapies have set a new standard for symptom control in rheumatoid arthritis, and blockade of tumour necrosis factor has the potential to protect joints from st...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(03)00032-8

    authors: Taylor PC

    更新日期:2003-06-01 00:00:00

  • Imaging of neuronal activity in the gut.

    abstract::Over the past few years, several groups have used voltage-sensitive dyes or calcium-indicator dyes to optically monitor the activity of several enteric neurons simultaneously. Some of the initial practical problems have been solved and these studies have successfully shown the spread of electrical activation within th...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(01)00097-2

    authors: Vanden Berghe P,Bisschops R,Tack J

    更新日期:2001-12-01 00:00:00

  • The case for a role for adenosine in asthma: almost convincing?

    abstract::Mice rendered adenosine deaminase-deficient manifest an 'asthma' phenotype in the lungs that includes mast cell degranulation, eosinophilia, mucus hypersecretion and bronchial hyperresponsiveness. These changes can be reversed by enzyme therapy with adenosine deaminase, and attenuated by theophylline. Theophylline als...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(03)00039-0

    authors: Fozard JR

    更新日期:2003-06-01 00:00:00

  • Oxidative stress-elicited myocardial apoptosis during reperfusion.

    abstract::Myocardial apoptosis primarily triggered during reperfusion has been associated with cardiac dysfunction and extension of infarction. Although potential signaling pathways involved in triggering apoptosis remain to be clearly defined, an increasing number of experiments have implicated the generation of reactive oxyge...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2003.10.010

    authors: Zhao ZQ

    更新日期:2004-04-01 00:00:00

  • Drug delivery to the upper small intestine window using gastroretentive technologies.

    abstract::The bioavailability of drugs with an absorption window in the upper small intestine is generally limited with conventional pharmaceutical dosage forms. The residence time of such systems and, thus, of their drug release into the stomach and upper intestine is often short. To overcome this restriction and to increase t...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2006.04.007

    authors: Streubel A,Siepmann J,Bodmeier R

    更新日期:2006-10-01 00:00:00

  • Mechanism of action of general anaesthetics--new information from molecular pharmacology.

    abstract::Major progress in our understanding of the mechanisms of anaesthesia has been made during the past year. Several key advances in defining very specific sites of action on ligand-gated ion channels have been described. Furthermore, new techniques have become available for addressing the identification of binding sites ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/s1471-4892(01)00013-3

    authors: Thompson SA,Wafford K

    更新日期:2001-02-01 00:00:00

  • Host immune modulation by antimicrobial drugs: current knowledge and implications for antimicrobial chemotherapy.

    abstract::It is known that antimicrobial agents possess several, beneficial, secondary properties which complement their primary antimicrobial activity like the immunomodulatory capacity that enforces host defense mechanisms or reduces host inflammatory response. In this review the current state of our recent research about the...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2014.07.011

    authors: Banche G,Allizond V,Mandras N,Tullio V,Cuffini AM

    更新日期:2014-10-01 00:00:00

  • Non-nucleoside reverse transcriptase inhibitors (NNRTIs): a brief overview of clinically approved drugs and combination regimens.

    abstract::The non-nucleoside reverse transcriptase inhibitors (NNRTIs) are allosteric inhibitors of HIV-1 reverse transcriptase and are classified into generations depending on their discovery and resistance profiles. The NNRTIs are used in combination regimens with antiretroviral agents that target two or more enzymes in the v...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2020.10.009

    authors: Vanangamudi M,Kurup S,Namasivayam V

    更新日期:2020-10-01 00:00:00

  • Therapeutic opportunities in the B7/CD28 family of ligands and receptors.

    abstract::The CD28 and B7 protein families are critical regulators of immune responses and, in the past few years, several new family members have been identified. Preclinical studies exploring the role of members of the CD28 and B7 families support the targeting of these pathways for new therapeutic approaches. Indeed, recent ...

    journal_title:Current opinion in pharmacology

    pub_type: 杂志文章,评审

    doi:10.1016/j.coph.2005.02.003

    authors: Carreno BM,Carter LL,Collins M

    更新日期:2005-08-01 00:00:00